日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identification of Hidden Cachexia Subgroup in PD-L1-High NSCLC: Comparative Analysis of the AWGC vs. Fearon Criteria

PD-L1高表达非小细胞肺癌中隐匿性恶病质亚组的识别:AWGC标准与Fearon标准的比较分析

Nishioka, Naoya; Kawachi, Hayato; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Ogawa, Takeo; Iwasaku, Masahiro; Tokuda, Shinsaku; Kijima, Takashi; Takayama, Koichi

Gut microbiome-driven modulation of the tumor immune microenvironment optimizes dual checkpoint blockade in advanced non-small-cell lung cancer

肠道微生物群驱动的肿瘤免疫微环境调控可优化晚期非小细胞肺癌的双重检查点阻断疗法

Katayama, Y; Fukuda, A; Inoue, R; Kawachi, H; Sawada, R; Harada, T; Yoshimura, A; Okada, A; Shiotsu, S; Chihara, Y; Takemura, Y; Yamada, T; Nishioka, N; Iwasaku, M; Tokuda, S; Takagi, T; Kumagai, S; Koyama, S; Takayama, K; Yamada, T

A Randomized Trial of Nutrition and Exercise Treatment in Patients With Pancreatic and Non-Small Cell Lung Cancer (NEXTAC-TWO)

一项针对胰腺癌和非小细胞肺癌患者的营养和运动治疗随机试验(NEXTAC-TWO)

Mitsunaga, Shuichi; Naito, Tateaki; Imai, Hisao; Kimura, Madoka; Miura, Satoru; Tanaka, Hisashi; Mizukami, Takuro; Imoto, Akira; Kondoh, Chihiro; Okuyama, Hiroyuki; Ueno, Makoto; Shiotsu, Shinsuke; Inano, Toshimi; Chitose, Haruka; Tatematsu, Noriatsu; Okayama, Taro; Mouri, Takako; Sugiyama, Miwa; Omae, Katsuhiro; Kawabata, Takanori; Mori, Keita; Takayama, Koichi

Impact of the Lung Immune Prognostic Index in non-small-cell lung cancer patients with PD-L1-low/negative tumors receiving chemoimmunotherapy: a real-world multicenter retrospective study

肺免疫预后指数对接受化疗免疫治疗的PD-L1低表达/阴性非小细胞肺癌患者的影响:一项真实世界多中心回顾性研究

Yoshimura, A; Takeda, T; Tanimura, K; Chihara, Y; Kawachi, H; Yamanaka, Y; Tamiya, N; Honda, R; Yamada, T; Uryu, K; Shiotsu, S; Yoshioka, H; Yamada, T; Kurata, T; Takayama, K

Prognostic factors in patients with interstitial lung disease treated with nintedanib: a multicenter retrospective study in Japan

日本一项多中心回顾性研究探讨了接受尼达尼布治疗的间质性肺病患者的预后因素。

Goda, Shiho; Yamada, Tadaaki; Goto, Yasuhiro; Uda, Sayaka; Nakao, Akira; Shiotsu, Shinsuke; Kukida, Yuji; Tanimura, Keiko; Miyamoto, Akifumi; Imasato, Yuki; Okada, Asuka; Hasegawa, Isao; Date, Koji; Matsui, Yohei; Morito, Shoki; Inoguchi, Noeru; Osugi, Shuji; Kawachi, Hayato; Nishioka, Naoya; Iwasaku, Masahiro; Tokuda, Shinsaku; Handa, Tomohiro; Takayama, Koichi

Impact of TTF-1 Expression on the Prognostic Prediction of Patients with Non-Small Cell Lung Cancer with PD-L1 Expression Levels of 1% to 49%, Treated with Chemotherapy vs. Chemoimmunotherapy: A Multicenter, Retrospective Study

TTF-1表达对PD-L1表达水平为1%至49%的非小细胞肺癌患者接受化疗与化疗免疫治疗预后预测的影响:一项多中心回顾性研究

Nishioka, Naoya; Hata, Tae; Yamada, Tadaaki; Goto, Yasuhiro; Amano, Akihiko; Negi, Yoshiki; Watanabe, Satoshi; Furuya, Naoki; Oba, Tomohiro; Ikoma, Tatsuki; Nakao, Akira; Tanimura, Keiko; Taniguchi, Hirokazu; Yoshimura, Akihiro; Fukui, Tomoya; Murata, Daiki; Kaira, Kyoichi; Shiotsu, Shinsuke; Hibino, Makoto; Okada, Asuka; Chihara, Yusuke; Kawachi, Hayato; Kijima, Takashi; Takayama, Koichi

Selecting optimal immunotherapy based on inflammation in stage IV PD-L1 ≥50% gene mutation-negative non-small cell lung cancer: pembrolizumab monotherapy versus combination chemoimmunotherapy

基于炎症情况选择最佳免疫疗法治疗PD-L1 ≥50%基因突变阴性IV期非小细胞肺癌:帕博利珠单抗单药治疗与联合化疗免疫疗法

Kunimatsu, Yusuke; Nishioka, Naoya; Yamada, Tadaaki; Kawachi, Hayato; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Ishida, Masaki; Kijima, Takashi; Takayama, Koichi

Impact of immune-related adverse events on clinical outcomes in patients with advanced non-small cell lung cancer with low PD-L1 expression, focusing on pneumonitis: a multicenter retrospective study in Japan

免疫相关不良事件对PD-L1低表达晚期非小细胞肺癌患者临床结局的影响,以肺炎为重点:一项日本多中心回顾性研究

Goda, Shiho; Yamada, Tadaaki; Morimoto, Kenji; Hata, Tae; Goto, Yasuhiro; Amano, Akihiko; Negi, Yoshiki; Watanabe, Satoshi; Furuya, Naoki; Oba, Tomohiro; Ikoma, Tatsuki; Nakao, Akira; Tanimura, Keiko; Taniguchi, Hirokazu; Yoshimura, Akihiro; Fukui, Tomoya; Murata, Daiki; Kaira, Kyoichi; Shiotsu, Shinsuke; Okada, Asuka; Hibino, Makoto; Chihara, Yusuke; Kijima, Takashi; Takayama, Koichi

Outcomes of chemotherapy with or without immunotherapy in older patients with non-small cell lung cancer and low PD-L1 expression

老年非小细胞肺癌低PD-L1表达患者接受化疗(联合或不联合免疫治疗)的疗效

Kawachi, Hayato; Hata, Tae; Yamada, Tadaaki; Goto, Yasuhiro; Amano, Akihiko; Negi, Yoshiki; Watanabe, Satoshi; Furuya, Naoki; Oba, Tomohiro; Ikoma, Tatsuki; Nakao, Akira; Tanimura, Keiko; Taniguchi, Hirokazu; Yoshimura, Akihiro; Fukui, Tomoya; Murata, Daiki; Kaira, Kyoichi; Shiotsu, Shinsuke; Hibino, Makoto; Okada, Asuka; Chihara, Yusuke; Kijima, Takashi; Takayama, Koichi

Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1-Expressing Non-Small Cell Lung Cancer

晚期低PD-L1表达非小细胞肺癌患者的化疗免疫治疗结果和预后因素

Hata, Tae; Yamada, Tadaaki; Goto, Yasuhiro; Amano, Akihiko; Negi, Yoshiki; Watanabe, Satoshi; Furuya, Naoki; Oba, Tomohiro; Ikoma, Tatsuki; Nakao, Akira; Tanimura, Keiko; Taniguchi, Hirokazu; Yoshimura, Akihiro; Fukui, Tomoya; Murata, Daiki; Kaira, Kyoichi; Shiotsu, Shinsuke; Hibino, Makoto; Okada, Asuka; Chihara, Yusuke; Kawachi, Hayato; Kijima, Takashi; Takayama, Koichi